Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity

NCT02442375 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms
Carcinoma, Squamous Cell

Interventions

RADIATION: standard dose prescription
RADIATION: FDG-PET guided gradient dose prescription

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]